Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 09, 2026
Why Is Noah Holdings (NOAH) Stock Down -13% Today?

Why Is Noah Holdings (NOAH) Stock Down -13% Today?

Key Takeaways

  • Noah Holdings shares are trading roughly 13% lower in premarket action on Thursday, largely reflecting the stock going ex-dividend rather than a fundamental deterioration in the business.
  • The primary driver is the combined final and special dividend of USD 0.69032 per ADS each (approximately USD 1.38 total), with July 9, 2026 marking both the ex-dividend and record date.
  • The dividend was declared following Noah's June annual general meeting, where shareholders approved a total payout equal to roughly RMB612 million, split evenly between a final dividend tied to 2025 earnings and a special dividend from accumulated surplus cash.
  • Broader sentiment around Chinese ADRs remains a secondary factor, as U.S.-listed Chinese equities have faced periodic volatility this year amid regulatory and trade-related headlines.
  • No negative operational news, earnings miss, or downgrade appears to be driving the move; Noah's most recent Q1 2026 results highlighted continued growth in AI-driven wealth management offerings.
  • Traders are now watching whether the stock stabilizes near its adjusted post-dividend price and how the market absorbs the cash payout heading into the August 6, 2026 distribution date.

Opening Summary

Noah Holdings Limited (NOAH) is a Shanghai-based wealth and asset management firm that serves Mandarin-speaking high-net-worth investors globally through its Gopher and Olive asset management platforms. Shares are down approximately 13% in premarket trading Thursday, falling from Wednesday's close of $10.34 to around $9.00, but the move is technical rather than a signal of business weakness. The stock's decline directly corresponds to its ex-dividend date, when NOAH began trading without the value of an upcoming combined final and special dividend of $1.38065 per ADS. This mechanical adjustment, not a change in company fundamentals, is the immediate reason cited for the sharp gap-down.

Dividend-Driven Price Adjustment

Noah's board approved a final dividend of RMB306.0 million and a special dividend of RMB306.0 million at its June annual general meeting, together equal to RMB1.866 per share, or roughly USD 1.38 per ADS. Because U.S. markets typically adjust a stock's opening price downward by the dividend amount on the ex-dividend date, NOAH's roughly 13% premarket drop closely tracks the dividend's proportion of its prior closing price. The final dividend is tied to 50% of the company's non-GAAP net income for fiscal year 2025, while the special dividend draws from previously accumulated surplus cash, reflecting an active capital-return strategy rather than distress. Shareholders of record as of today will receive payment around August 6, 2026 for ADS holders.

Sector and Sentiment Backdrop

Chinese ADRs listed in the U.S. have experienced intermittent bouts of volatility this year tied to regulatory scrutiny and shifting trade rhetoric between Washington and Beijing. While these macro currents can weigh on sentiment across the sector, they are not cited as the direct catalyst for Thursday's move in Noah Holdings (NOAH), which remains overwhelmingly attributable to the dividend adjustment. Investors tracking Chinese wealth management and financial services names may still want to monitor broader U.S.-China developments for any spillover effects on peer stocks.

Market Context and Trading Activity

Trading volume in NOAH has been in line with recent averages ahead of the open, consistent with a scheduled corporate action rather than a surprise news event. The stock had been on a modest upward trajectory into the ex-dividend date, closing at $10.34 on July 6 after touching $86 highs are unrelated—Noah's own 52-week range has been considerably lower, and the shares were trading near the bottom of that range prior to the adjustment. Because the move is a scheduled price adjustment tied to the dividend record date rather than a market-driven repricing, it does not reflect a break of technical support or resistance levels in the traditional sense.

Trending AI Robots

Traders monitoring stocks like Noah Holdings (NOAH) around corporate actions such as ex-dividend dates may find value in Tickeron's Trending AI Robots page. Tickeron operates hundreds of AI-driven trading bots spanning thousands of tickers, but only the top-performing strategies under current market conditions are featured in this curated section. These bots differ by strategy type, trading timeframe, historical performance metrics, and the specific symbols they cover, offering a snapshot of which automated approaches are currently generating strong results. Investors interested in systematic ways to navigate dividend-related price adjustments and other market events can explore the Trending AI Robots section for additional perspective on algorithmic trading tools.

What Comes Next for NOAH

Looking forward, investors will watch for Noah's second-quarter 2026 earnings release, which should provide updated figures on assets under management and investment product distribution following the RMB140.2 billion AUM reported as of March 31, 2026. The company's continued emphasis on AI-driven wealth management tools and global expansion for Mandarin-speaking clients will remain a focal point for analysts assessing growth prospects. Broader risks include regulatory developments affecting Chinese ADRs, currency fluctuations between the RMB and USD that affect dividend conversion values, and any shifts in U.S.-China trade policy that could influence sentiment across the sector.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: NOAH

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


NOAH in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 29, 2026

NOAH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 34 of 41 cases where NOAH's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for NOAH's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where NOAH advanced for three days, in 168 of 258 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NOAH as a result. In 66 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.

The Moving Average Convergence Divergence Histogram (MACD) for NOAH turned negative on September 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 42 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NOAH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.

The Aroon Indicator for NOAH entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.393) is normal, around the industry mean (3.242). P/E Ratio (6.324) is within average values for comparable stocks, (26.802). NOAH's Projected Growth (PEG Ratio) (6.620) is very high in comparison to the industry average of (1.341). Dividend Yield (0.082) settles around the average of (0.081) among similar stocks. P/S Ratio (1.439) is also within normal values, averaging (15.853).

The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. NOAH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NOAH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.

Notable companies

The most notable companies in this group are Ares Capital Corp (NASDAQ:ARCC), WisdomTree (NYSE:WT), AMTD IDEA Group (NYSE:AMTD).

Industry description

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

Market Cap

The average market capitalization across the Investment Managers Industry is 8.63B. The market cap for tickers in the group ranges from 57 to 165.9B. BLK holds the highest valuation in this group at 165.9B. The lowest valued company is RSERF at 57.

High and low price notable news

The average weekly price growth across all stocks in the Investment Managers Industry was 0%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 8%. SDEV experienced the highest price growth at 151%, while INV experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Investment Managers Industry was 35%. For the same stocks of the Industry, the average monthly volume growth was 93% and the average quarterly volume growth was 18%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 30
P/E Growth Rating: 53
Price Growth Rating: 55
SMR Rating: 67
Profit Risk Rating: 81
Seasonality Score: 38 (-100 ... +100)
View a ticker or compare two or three
NOAH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of investment advisory and wealth management services

Industry InvestmentManagers

Industry
Investment Banks Or Brokers
Address
No. 1226 South Shenbin Road
Phone
+86 4008200025
Employees
1778
Web
https://www.noahgroup.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
NBR stock rose approximately +12% over the last 30 days, driven by positive momentum in the oil and gas drilling sector and strong Q4 earnings beat. Over the past quarter, the stock surged +58%, fueled by robust YTD performance, debt reduction efforts, and improved operational results in international drilling.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.